Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis
Phase 3
Completed
- Conditions
- Eyelash Hypotrichosis
- Interventions
- First Posted Date
- 2011-07-12
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Allergan
- Target Recruit Count
- 36
- Registration Number
- NCT01391286
Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity
Completed
- Conditions
- Muscle Spasticity
- Interventions
- Biological: botulinum toxin Type A
- First Posted Date
- 2011-07-04
- Last Posted Date
- 2014-02-03
- Lead Sponsor
- Allergan
- Target Recruit Count
- 108
- Registration Number
- NCT01387074
Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical Dystonia
Phase 4
Completed
- Conditions
- Torticollis
- Interventions
- Biological: botulinum toxin Type A
- First Posted Date
- 2011-06-29
- Last Posted Date
- 2011-06-29
- Lead Sponsor
- Allergan
- Target Recruit Count
- 28
- Registration Number
- NCT01384214
Retrospective Study of Patients With Spasticity in the Spanish Population
Completed
- Conditions
- Muscle Spasticity
- Interventions
- Other: No treatment
- First Posted Date
- 2011-06-28
- Last Posted Date
- 2013-11-14
- Lead Sponsor
- Allergan
- Target Recruit Count
- 235
- Registration Number
- NCT01383681
Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss
Phase 2
Completed
- Conditions
- BaldnessAlopecia
- Interventions
- First Posted Date
- 2011-03-29
- Last Posted Date
- 2014-04-09
- Lead Sponsor
- Allergan
- Target Recruit Count
- 306
- Registration Number
- NCT01325350
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
Phase 2
Completed
- Conditions
- AlopeciaBaldnessAlopecia, Androgenetic
- Interventions
- First Posted Date
- 2011-03-29
- Last Posted Date
- 2014-04-10
- Lead Sponsor
- Allergan
- Target Recruit Count
- 307
- Registration Number
- NCT01325337
Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye
Phase 1
Completed
- Conditions
- Dry Eye Syndromes
- First Posted Date
- 2011-03-22
- Last Posted Date
- 2015-09-07
- Lead Sponsor
- Allergan
- Target Recruit Count
- 44
- Registration Number
- NCT01319773
Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy
Completed
- Conditions
- Vitrectomy
- Interventions
- Procedure: Pars Plana Vitrectomy
- First Posted Date
- 2011-03-21
- Last Posted Date
- 2013-07-02
- Lead Sponsor
- Allergan
- Target Recruit Count
- 25
- Registration Number
- NCT01319318
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Phase 4
Completed
- Conditions
- GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-02-18
- Last Posted Date
- 2018-09-17
- Lead Sponsor
- Allergan
- Target Recruit Count
- 806
- Registration Number
- NCT01298700
- Locations
- 🇮🇱
Glaucoma Service The Rabin Medical Center, Petach Tiqva, Israel
🇮🇱Kaplan Medical Center, Rehovot, Israel
🇧🇪UZ Leuven, Leuven, Belgium
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
Phase 3
Completed
- Conditions
- Dry Eye Syndromes
- Interventions
- First Posted Date
- 2011-02-11
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- Allergan
- Target Recruit Count
- 305
- Registration Number
- NCT01294384
© Copyright 2025. All Rights Reserved by MedPath